株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の新生児スクリーニング市場:業界分析と市場予測

Global Newborn Screening Market - Industry Analysis and Market Forecast (2016 - 2021)

発行 Mordor Intelligence LLP 商品コード 319330
出版日 ページ情報 英文 193 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
世界の新生児スクリーニング市場:業界分析と市場予測 Global Newborn Screening Market - Industry Analysis and Market Forecast (2016 - 2021)
出版日: 2016年08月01日 ページ情報: 英文 193 Pages
概要

代謝性疾患や遺伝性疾患が様々な形で乳児の通常の身体的、精神的発達を妨げることがあります。今や簡単な血液検査によって、新生児が最終的に問題となる症状をもっているかどうかを判定することができます。早期に診断し適切な治療をすることで、その後の発達に大きな違いをもたらすことがあります。

当レポートでは、世界の新生児スクリーニング市場について調査し、スクリーニングされる一般的な疾患、検査の種類、技術概要などをまとめています。

第1章 概要

第2章 スクリーニングされる最も一般的な疾患

  • PKU
  • 先天性甲状腺機能低下症
  • ガラクトース血症
  • 鎌状赤血球病
  • ビオチニダーゼ欠損
  • 先天性副腎過形成
  • メープルシロップ尿症
  • チロシン血症
  • 嚢胞性線維症
  • MCAD欠損
  • トキソプラズマ症
  • 聴覚スクリーニング

第3章 新生児スクリーニング市場のカテゴリー

  • 検査の種類
    • 血液検査
    • 聴覚検査
    • 先天性心疾患検査
    • パルスオキシメトリ

第4章 新生児スクリーニング市場:技術別

  • タンデム質量分析
  • ヘモグロビン電気泳動検査
  • 免疫測定および酵素アッセイ
  • 聴覚スクリーニング
  • パルスオキシメトリスクリーニング

第5章 免責事項

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The global newborn screening market is expected to reach USD XX million by 2021, growing at a CAGR of XX%. Newborn screening is performed to screen infants after birth for the detection of any health conditions or diseases that can be fatal but are not detected during birth. The newborn screening tests are basically an evaluation of metabolites and blood samples. These tests vary according to different country jurisdictions. In many areas, newborn screening tests include screening for hearing loss and congenital heart disease. The major diseases screened for are sickle cell disease, cystic fibrosis, newborn hearing loss, congenital hypothyroidism, phenyl ketone urea and congenital heart disease.

Global Newborn Screening Market- Market Dynamics

The report details several driving and restraining factors for the global newborn screening market. Some of them are listed below.

Drivers

  • Presence of federal bodies for organizing awareness programs
  • Increasing awareness in developed countries
  • Technological advancements in healthcare
  • Increasing array of newborn diseases
  • More physicians advising newborn screening tests

Restraints

  • Lack of awareness in developing countries
  • Lack of trained professionals
  • Socio-economic barriers in developing countries

The global newborn screening market has been segmented based on technology, product, test type, and geography. The segmentation based on technology has been subdivided into tandem mass spectrometry, DNA-based assay, enzyme, and immunoassays, electrophoresis, hearing screening technology, and pulse oximetry technology. The segmentation based on product is sub-divided into newborn disorder screening instruments, hearing screening devices and accessories, pulse oximetry, and reagents and assay kits. The segmentation based on test type has been sub-divided into critical congenital heart disease test, hearing screening test, and dry blood spot test.

Amongst technologies being used, tandem mass spectrometry is expected to have the highest growth rate during the forecast period. The dry blood spot test has the largest market share in the segment by test type.

Based on geography, the global newborn screening test market has been segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The segmentation on North America discusses different market trends, and market size of newborn screening tests in the USA, Canada, and Mexico. The Europe segment has been further subdivided into UK, France, Italy, Germany, Benelux, Scandinavia, Spain and Portugal. The segmentation on Asia-Pacific has been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle-east & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, Colombia and others.

Some of the key players in the market are:

  • AB Sciex LLC
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Covidien PLC
  • PerkinElmer Inc.
  • Trivitron Healthcare

What the Report Offers

  • Market definition for the global newborn screening market along with identification of key drivers and restraints for the market.
  • Market analysis for the newborn screening test market, with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the newborn screening test market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. Introduction

  • 1.1. Study deliverables
  • 1.2. Market Definition
  • 1.3. Sizing Units
  • 1.4. Base Currency
  • 1.5. Review and Forecast period years
  • 1.6. General Study Assumptions

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Analysis Methodology
  • 2.3. Econometric Forecast Model
  • 2.4. Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry trends

  • 5.1. Current Market Scenario
  • 5.2. Newborn Screening test Applications
  • 5.3. Technology Overview
  • 5.4. New Developments
  • 5.5. Industry Value chain analysis
  • 5.6. Product Lifecycle analysis
  • 5.7. Product Benchmarking
  • 5.8. Investment Analysis
  • 5.9. Porter's Five Forces
    • 5.9.1. Bargaining Power of Suppliers
    • 5.9.2. Bargaining Power of Consumers
    • 5.9.3. Threat to new entrants
    • 5.9.4. Threat to substitute products and services
    • 5.9.5. Competitive Rivalry within the industry

6. Drivers, Restraints, Opportunities, and challenges Analysis

  • 6.1. Market Drivers
    • 6.1.1. Presence of federal bodies for organizing awareness programs
    • 6.1.2. Increasing awareness in Developed countries
    • 6.1.3. Technological Advancements
    • 6.1.4. Government support
    • 6.1.5. Increasing array of newborn diseases
  • 6.2. Market Restraints
    • 6.2.1. Lack of awareness in developing countries
    • 6.2.2. Lack of trained professional
    • 6.2.3. Socio- economic barriers in developing nations
      • 6.2.3.1. Market Opportunities
      • 6.2.3.2. Government Initiatives
      • 6.2.3.3. Market Challenges
  • 6.3. Lack of advanced healthcare facilities in developing nations
  • 6.4. Lack of awareness amongst a large population globally

7. Global Newborn Screening Market segmentation

  • 7.1. Introduction
  • 7.2. Segmentation by Technology
    • 7.2.1. Tandem Mass Spectrometry
    • 7.2.2. DNA based assay
    • 7.2.3. Enzymes and Immunoassays
    • 7.2.4. Electrophoresis
    • 7.2.5. Hearing Screen Technology
    • 7.2.6. Pulse Oximetry Technology
  • 7.3. Segmentation by Product
    • 7.3.1. Newborn disorder Screening Instruments
    • 7.3.2. Hearing screening devices, and Accessories
    • 7.3.3. Pulse Oximetry
    • 7.3.4. Reagents and assay kits
  • 7.4. Segmentation by test type
    • 7.4.1. Critical Congenital Heart Disease (CCHD) Test
    • 7.4.2. Hearing Screening Test
    • 7.4.3. Dry blood Spot Test

8. Market segmentation by Geography - North America

  • 8.1. North America
    • 8.1.1. Introduction
    • 8.1.2. United States
    • 8.1.3. Canada
    • 8.1.4. Mexico
  • 8.2. Europe
    • 8.2.1. Introduction
    • 8.2.2. Germany
    • 8.2.3. United Kingdom
    • 8.2.4. France
    • 8.2.5. Italy
    • 8.2.6. Spain
    • 8.2.7. Scandinavia
    • 8.2.8. BENELUX
    • 8.2.9. Rest of Europe
  • 8.3. Asia-Pacific (APAC)
    • 8.3.1. Introduction
    • 8.3.2. China
    • 8.3.3. Japan
    • 8.3.4. India
    • 8.3.5. Australia and New Zealand
    • 8.3.6. South Korea
    • 8.3.7. Rest of Asia-Pacific
  • 8.4. Middle East and North Africa
    • 8.4.1. Introduction
    • 8.4.2. GCC
    • 8.4.3. Egypt
    • 8.4.4. Rest of Middle East & Africa
  • 8.5. South America
    • 8.5.1. Introduction
    • 8.5.2. Brazil
    • 8.5.3. Argentina
    • 8.5.4. Rest of Latin America

9. Competitive Landscape

  • 9.1. Merger and acquisition analysis
  • 9.2. New Product Launches
  • 9.3. Agreements, Collaborations, and Partnerships

10. Key Vendor Analysis

  • 10.1. Agilent Technologies
  • 10.2. AB Sciex LLC
  • 10.3. Covidien PLC
  • 10.4. PerkinElmer Inc.
  • 10.5. Trivitron Healthcare
  • 10.6. Bio-Rad Laboratories
  • 10.7. Masimo Corporation
  • 10.8. Natus Medical
  • 10.9. Waters Corporation
  • 10.10. GE Healthcare

11. Analyst outlook for Investment opportunities

12. Future Outlook of the market

Back to Top